Impact of an 18-Month, NHS-Based, treatment exposure for heroin dependence: Results from the London area treat 2000 study

American Journal on Addictions

Volumn 21, Issue 3, 2012, Pages 268-273

  Schifano, Fabrizio ^a,b   Martinotti, Giovanni ^c   Cunniff, Anna ^d   Reissner, Volker ^e   Scherbaum, Norbert ^e   Ghodse, Hamid ^b  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CRIMINAL BEHAVIOR; DRUG MISUSE; EMPLOYMENT STATUS; FEMALE; HEALTH STATUS; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; SOCIAL SUPPORT; SUICIDAL IDEATION; UNITED KINGDOM;

ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COHORT STUDIES; CRIME; EMPLOYMENT; FEMALE; HEROIN DEPENDENCE; HUMANS; LONDON; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MENTAL HEALTH; METHADONE; OPIATE SUBSTITUTION TREATMENT; PROSPECTIVE STUDIES; PSYCHOTHERAPY; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84859879760     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00226.x     Document Type: Article

References (46)

1. Oppenheimer E, Tobutt C, Taylor C, et al. Death and survival in a cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction. 1994;89:1299-1308. (Pubitemid 24310621)
2. Hser YI, Hoffman V, Grella CE, et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503-508. (Pubitemid 32411332)
3. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction, 2002;97:963-967.
4. Webb L, Oyefeso A, Schifano F, et al. Cause and manner of death in drug-related fatality: An analysis of drug-related deaths recorded by coroners in England and Wales in 2000. Drug Alcohol Depend. 2003;72:67-74. (Pubitemid 37255331)
5. Gossop M, Marsden J, Stewart D, et al. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav. 2002;27:155-166. (Pubitemid 34003033)
6. Marsden J, Gossop M, Stewart D, et al. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry, 2000;176:285-289. (Pubitemid 30179850)
7. Rounsaville BJ, Weissman MM, Kleber H, et al. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry. 1982;39:161-168.
8. Godfrey C, Stewart D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction. 2004;99:697-707. (Pubitemid 38747907)
9. Ghodse AH, Reynolds M, Baldacchino AM, et al. Treating an opiate-dependent inpatient population: A one-year follow-up study of treatment completers and noncompleters. Addict Behav. 2002;27: 765-778. (Pubitemid 34712056)
10. Anglin MD, Hser Y, Grella CE. Drug addiction and treatment careers among clients in the drug abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;4:308-323. (Pubitemid 28046592)
11. Hubbard RL, Craddock SG, Flynn PM, et al. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:261-278. (Pubitemid 28046589)
12. Hubbard RL, Marsden ME, Cavanaugh E, et al. Drug Abuse Treatment: A Natural Study of Effectiveness. Durham, NC: The University of North Carolina Press; 1989.
13. Simpson DD, Joe GW, Bracey SA. Six-year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry. 1982;39:1318-1323. (Pubitemid 13232312)
14. Gossop M, Marsden J, Stewart D, et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 1998;173:166-171. (Pubitemid 28368367)
15. Darke S, Williamson A, Ross J, et al. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study. Drug Alcohol Depend. 2006;84:201-205. (Pubitemid 44119098)
16. Flynn PM, Joe GW, Broome KM, et al. Recovery from opioid addiction in DATOS. J Subst Abuse Treat. 2003;25:177-185.
17. Gossop M, Marsden J, Stewart D, et al. Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend. 1999;57:89-98. (Pubitemid 29505142)
18. Sánchez-Carbonell J, Cami J, et al. Follow-up of heroin addicts in Spain (EMETYST project):Results 1 year after treatment admission. Br J Addict. 1988;83:1439-1448. (Pubitemid 19045775)
19. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 1997;47:227-235. (Pubitemid 27412335)
20. Alterman AI, McLellan AT, Shifman RB. Do substance abuse patients with more psychopathology receive more treatment? J Nerv Ment Dis. 1993;81:576-582. (Pubitemid 24259644)
21. Havassy BE, Alvidrez J, Owen KK. Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery. Am J Psychiatry. 2004;161:139-145. (Pubitemid 38419319)
22. McKay JR, Weiss RV. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Preliminary results and methodological issues. Eval Rev. 2001;25:113-161. (Pubitemid 33602812)
23. Schifano F, Leoni M, Martinotti G, et al. Importance of cyberspace for the assessment of the drug abuse market: Preliminary results from the Psychonaut 2002 project. Cyberpsychol Behav. 2003;6:405-410. (Pubitemid 37087683)
24. Schifano F, Deluca P, Agosti L, et al. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol. 2005;19:675-679. (Pubitemid 41578831)
25. Ghodse H, Clancy C, Oyefeso A, et al. The impact of methadone substitution therapy (MST) on illicit drug use and drug abused-related quality of life: A European study. Heroin Addict Rel Cl. 2003;5:5-16.
26. Ghodse AH, Corkery J, Ahmed K, et al. Drug Related Deaths in the UK. Annual Report 2010. London: International Centre for Drug Policy, St George's, University of London (UK); 2010.
27. Scherbaum N, Reissner V, Di Furia L, et al. Vergleich der Behandlungsnetze für Drogenabhängige in Europa - Das TREAT-Projekt. Nervenarzt. 2003;74 (9 Suppl 2):S268.
28. Reissner V, Kokkevi A, DiFuria L, et al. Drug consumption, health service use and outcome in opiate addicts in Europe: An 18-month follow-up from Athens to Zurich. European Psychiatry. 2008;23(Suppl 2):S74.
29. Kessler RC, Ustun B. Properties of the Composite International Diagnostic Interview (CIDI) for Measuring Mental Health Outcome. Gaskell, Max Planck Society-eDocument Server (Germany); 2001.
30. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument. Drug Alcohol Depend. 1995;1:208-210.
31. Chwastiak LA, von Korff M. Disability in depression and back pain: Evaluation of the WHO Disability Assessment Schedule (WHO-DAS- II) in a primary care setting. J Clin Epidemiol. 2003;56: 507-514. (Pubitemid 36842907)
32. Vazquez-Barquero JL, Vazquez BE, et al. Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): Initial phase of development and pilot study. Cantabria Disability Work Group. Actas Esp Psiquiatr. 2000;28:77-87.
33. Dunkel-Schetter C, Feinstein L, Call J. UCLA-Social Support Inventory (UCLA-SSI). Unpublished psychometric instrument. Los Angeles: University of California; 1986.
34. Gossop M, Green L, Phillips G, et al. Lapse, relapse and survival among opiate addicts immediately after treatment: A prospective follow-up study. Br J Psychiatry. 1989;154:348-353. (Pubitemid 19091811)
35. Chutuape MA, Jasinski DR, Fingerhood MI, et al. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27:19-44. (Pubitemid 32428986)
36. Gerstein DR, Harwood HJ. Treating drug problems. A Study of Effectiveness and Financing of Public and Private Drug Treatment Systems. Washington DC: Institute of Medicine National Academy Press; 1990.
37. Mattick RM, Hall W. Are detoxification programmes effective? Lancet. 1996;347:97-100. (Pubitemid 26017858)
38. Williamson A, Darke S, Ross J, et al. The association between cocaine use and short-termoutcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev. 2006;25:141-148. (Pubitemid 43688728)
39. Williamson A, Darke S, Ross J, et al. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: Findings from the Australian Treatment Outcome Study. J Subst Abuse Treat. 2007;33:287-293. (Pubitemid 47418581)
40. Darke S. Polydrug use and overdose: Overthrowing old myths. Addiction. 2003;98:711. (Pubitemid 36688049)
41. Druid H, Strandberg JJ, Alkas K, et al. Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis. Forensic Sci Int. 2007;168:223-226. (Pubitemid 46617839)
42. Martinotti G, Carli V, Tedeschi D, et al. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addict Behav. 2009;34:790-793.
43. Fairbank JA, Dunteman GH, Condelli WS. Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. Am J Drug Alcohol Abuse. 1993;19:465-474. (Pubitemid 23319988)
44. Fugelstad A, Ahlner J, Brandt L, et al. Use of morphine and 6- monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction. 2003;98:463-470. (Pubitemid 36458128)
45. Karch SB. Karch's Pathology of Drug Abuse. Boca Raton, FL: CRC Press; 2002.
46. Platt JJ. Vocational rehabilitation of drug abusers. Psychol Bull. 1995;117:416-433.